🏛️ Verified NIH Record • Updated 2026-04-26
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus (NCT07321678)
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic Sponsor: Ascletis Pharma (China) Co., Limited
🩺 Plain-English Summary (8th-Grade Level)
This randomized, double-blind, placebo-controlled Phase II study is designed to evaluate the efficacy, safety, and tolerability of ASC30 oral tablets formulation in participants with Type 2 Diabetes Mellitus
Who can join: Review the eligibility criteria below.
Location: Ascletis Clinical Site — Riverside, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (8 Sites)
- Ascletis Clinical Site — Riverside, California
- Ascletis Clinical Site — San Jose, California
- Ascletis Clinical Site — Denver, Colorado
- Ascletis Clinical Site — Miami, Florida
- Ascletis Clinical Site — Miami, Florida
- Ascletis Clinical Site — Decatur, Georgia
- Ascletis Clinical Site — Springfield, Missouri
- Ascletis Clinical Site — San Antonio, Texas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in T2DM (Type 2 Diabetes Mellitus)
- Virtual Diabetes Group Visits Across Health Systems — Chicago, Illinois
- Utilization Study and Evaluation of Educational Intervention on HbA1c Testing — Vancouver, British Columbia
- Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D. — Columbus, Ohio
Explore by condition: All T2DM (Type 2 Diabetes Mellitus) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.